• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析患者心血管事件风险预测模型的系统评价与荟萃分析

Systematic review and meta-analysis of cardiovascular event risk prediction models in maintenance hemodialysis patients.

作者信息

Zhou Yaping, He Yining, Zhu Peiqi, Yan Ruxue, Tang Ruijie, Wang Lanhui, He Weiming

机构信息

Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China.

出版信息

Sci Rep. 2025 Jul 1;15(1):21807. doi: 10.1038/s41598-025-07586-2.

DOI:10.1038/s41598-025-07586-2
PMID:40595306
Abstract

This research pursues a systematic review and meta-analysis concerning the cardiovascular event risk prediction models for maintenance hemodialysis patients. Through systematic literature searching, the titles and abstracts of 23,707 related papers were initially screened, ultimately including 16 papers covering 17 prediction models. The results reveal that among these models, a total of 16 predictive variables were chosen at least twice, with age, diabetes history, and history of cardiovascular disease being the primary predictors. Regarding model validation, 14 models underwent internal validation, 3 models underwent external validation, while 3 models were not subjected to any form of validation. Additionally, calibration testing was performed on 14 models. Risk of bias assessment showed that only 1 model was rated as low risk bias, while the other models were rated as high risk bias due to issues with study cohort characteristics and methodology. Meta-analysis results showed that the combined C-statistic for 13 prediction models was 0.80 (95%CI = 0.74, 0.86), and no significant publication bias was detected. Thus, future construction and validation of prediction models should strictly follow reliable methodological standards and enhance external validation to provide more reliable evidence-based guidance for predicting cardiovascular event risk in maintenance hemodialysis patients.

摘要

本研究对维持性血液透析患者心血管事件风险预测模型进行了系统评价和荟萃分析。通过系统的文献检索,初步筛选了23707篇相关论文的标题和摘要,最终纳入16篇论文,涵盖17个预测模型。结果显示,在这些模型中,共有16个预测变量被至少选用两次,其中年龄、糖尿病史和心血管疾病史是主要预测因素。在模型验证方面,14个模型进行了内部验证,3个模型进行了外部验证,3个模型未进行任何形式的验证。此外,对14个模型进行了校准测试。偏倚风险评估显示,只有1个模型被评为低风险偏倚,其他模型由于研究队列特征和方法学问题被评为高风险偏倚。荟萃分析结果显示,13个预测模型的合并C统计量为0.80(95%CI = 0.74, 0.86),未检测到明显的发表偏倚。因此,未来预测模型的构建和验证应严格遵循可靠的方法学标准,加强外部验证,为预测维持性血液透析患者心血管事件风险提供更可靠的循证指导。

相似文献

1
Systematic review and meta-analysis of cardiovascular event risk prediction models in maintenance hemodialysis patients.维持性血液透析患者心血管事件风险预测模型的系统评价与荟萃分析
Sci Rep. 2025 Jul 1;15(1):21807. doi: 10.1038/s41598-025-07586-2.
2
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于维持克罗恩病的缓解状态。
Cochrane Database Syst Rev. 2015 Oct 30;2015(10):CD000067. doi: 10.1002/14651858.CD000067.pub3.
10
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.

本文引用的文献

1
Hemodialysis Vascular Access: Core Curriculum 2025.血液透析血管通路:2025年核心课程
Am J Kidney Dis. 2025 Feb;85(2):236-252. doi: 10.1053/j.ajkd.2024.05.021. Epub 2024 Dec 3.
2
Development and validation of a model for predicting the risk of cardiovascular events in maintenance hemodialysis patients.开发和验证一种用于预测维持性血液透析患者心血管事件风险的模型。
Sci Rep. 2024 Mar 21;14(1):6760. doi: 10.1038/s41598-024-55161-y.
3
Advances in the management of chronic kidney disease.慢性肾脏病管理的进展。
BMJ. 2023 Dec 5;383:e074216. doi: 10.1136/bmj-2022-074216.
4
Development and Validation of Prediction Models for All-Cause Mortality and Cardiovascular Mortality in Patients on Hemodialysis: A Retrospective Cohort Study in China.在中国血液透析患者全因死亡率和心血管死亡率预测模型的开发和验证:一项回顾性队列研究。
Clin Interv Aging. 2023 Jul 28;18:1175-1190. doi: 10.2147/CIA.S416421. eCollection 2023.
5
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.临床和动态血压与死亡率的关系:59124 例患者的观察性队列研究。
Lancet. 2023 Jun 17;401(10393):2041-2050. doi: 10.1016/S0140-6736(23)00733-X. Epub 2023 May 5.
6
Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association.中心维持性血液透析患者的高血压:当前证据与未来机遇:美国心脏协会科学声明。
Hypertension. 2023 Jun;80(6):e112-e122. doi: 10.1161/HYP.0000000000000230. Epub 2023 Apr 24.
7
Development of a prediction model to estimate the 5-year risk of cardiovascular events and all-cause mortality in haemodialysis patients: a retrospective study.开发一种预测模型以估计血液透析患者 5 年内心血管事件和全因死亡率的风险:一项回顾性研究。
PeerJ. 2022 Nov 9;10:e14316. doi: 10.7717/peerj.14316. eCollection 2022.
8
The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview.肾病科医生在多专科协作网络中照顾维持性血液透析糖尿病患者的作用:概述
J Clin Med. 2022 Mar 10;11(6):1521. doi: 10.3390/jcm11061521.
9
Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.启动透析以降低晚期慢性肾脏病患者死亡率和心血管事件的时机:全国队列研究。
BMJ. 2021 Nov 29;375:e066306. doi: 10.1136/bmj-2021-066306.
10
The role of hyperglycaemia in the development of diabetic cardiomyopathy.高血糖在糖尿病性心肌病发展中的作用。
Arch Cardiovasc Dis. 2021 Nov;114(11):748-760. doi: 10.1016/j.acvd.2021.08.004. Epub 2021 Oct 6.